FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1504439301> ?p ?o ?g. }

• W1504439301 endingPage "2765" @default.
• W1504439301 startingPage "2760" @default.
• W1504439301 abstract "BACKGROUND Total body irradiation (TBI) is widely used for conditioning before hematopoietic cell transplantation. Its efficacy and toxicity may depend on many methodological aspects. The goal of the current study was to explore current clinical practice in this field. METHODS A questionnaire was sent to all centers collaborating in the European Group for Blood and Marrow Transplantation and included 19 questions regarding various aspects of TBI. A total of 56 centers from 23 countries responded. RESULTS All centers differed with regard to at least 1 answer. The total maximum dose of TBI used for myeloablative transplantation ranged from 8 grays (Gy) to 14.4 Gy, whereas the dose per fraction was 1.65 Gy to 8 Gy. A total of 16 dose/fractionation modalities were identified. The dose rate ranged from 2.25 centigrays to 37.5 centigrays per minute. The treatment unit was linear accelerator (LINAC) (91%) or cobalt unit (9%). Beams (photons) used for LINAC were reported to range from 6 to 25 megavolts. The most frequent technique used for irradiation was “patient in 1 field,” in which 2 fields and 2 patient positions per fraction are used (64%). In 41% of centers, patients were immobilized during TBI. Approximately 93% of centers used in vivo dosimetry with accepted discrepancies between the planned and measured doses of 1.5% to 10%. In 84% of centers, the lungs were shielded during irradiation. The maximum accepted dose for the lungs was 6 Gy to 14.4 Gy. CONCLUSIONS TBI is an extremely heterogeneous treatment modality. The findings of the current study should warrant caution in the interpretation of clinical studies involving TBI. Further investigation is needed to evaluate how methodological differences influence outcome. Efforts to standardize the method should be considered. Cancer 2014;120:2760–2765. © 2014 American Cancer Society." @default.
• W1504439301 created "2016-06-24" @default.
• W1504439301 creator A5017225753 @default.
• W1504439301 creator A5019072713 @default.
• W1504439301 creator A5019349564 @default.
• W1504439301 creator A5020996390 @default.
• W1504439301 creator A5026667594 @default.
• W1504439301 creator A5040417184 @default.
• W1504439301 creator A5042552205 @default.
• W1504439301 creator A5058365219 @default.
• W1504439301 creator A5058925624 @default.
• W1504439301 creator A5071051754 @default.
• W1504439301 creator A5081996959 @default.
• W1504439301 date "2014-05-07" @default.
• W1504439301 modified "2023-10-06" @default.
• W1504439301 title "Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation" @default.
• W1504439301 cites W1522048276 @default.
• W1504439301 cites W1565345042 @default.
• W1504439301 cites W1897399860 @default.
• W1504439301 cites W1964698914 @default.
• W1504439301 cites W1968286526 @default.
• W1504439301 cites W1969143483 @default.
• W1504439301 cites W1973634030 @default.
• W1504439301 cites W1975303867 @default.
• W1504439301 cites W1979123982 @default.
• W1504439301 cites W1981325572 @default.
• W1504439301 cites W1985545566 @default.
• W1504439301 cites W1985883917 @default.
• W1504439301 cites W1996376330 @default.
• W1504439301 cites W2014220807 @default.
• W1504439301 cites W2031367735 @default.
• W1504439301 cites W2075566021 @default.
• W1504439301 cites W2105150447 @default.
• W1504439301 cites W2108962168 @default.
• W1504439301 cites W2118298035 @default.
• W1504439301 cites W2125288397 @default.
• W1504439301 cites W2135288559 @default.
• W1504439301 cites W2143327629 @default.
• W1504439301 cites W2154469177 @default.
• W1504439301 cites W2339482838 @default.
• W1504439301 cites W4240026283 @default.
• W1504439301 cites W4244166141 @default.
• W1504439301 cites W71007469 @default.
• W1504439301 doi "https://doi.org/10.1002/cncr.28768" @default.
• W1504439301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24804873" @default.
• W1504439301 hasPublicationYear "2014" @default.
• W1504439301 type Work @default.
• W1504439301 sameAs 1504439301 @default.
• W1504439301 citedByCount "69" @default.
• W1504439301 countsByYear W15044393012014 @default.
• W1504439301 countsByYear W15044393012015 @default.
• W1504439301 countsByYear W15044393012016 @default.
• W1504439301 countsByYear W15044393012017 @default.
• W1504439301 countsByYear W15044393012018 @default.
• W1504439301 countsByYear W15044393012019 @default.
• W1504439301 countsByYear W15044393012020 @default.
• W1504439301 countsByYear W15044393012021 @default.
• W1504439301 countsByYear W15044393012022 @default.
• W1504439301 countsByYear W15044393012023 @default.
• W1504439301 crossrefType "journal-article" @default.
• W1504439301 hasAuthorship W1504439301A5017225753 @default.
• W1504439301 hasAuthorship W1504439301A5019072713 @default.
• W1504439301 hasAuthorship W1504439301A5019349564 @default.
• W1504439301 hasAuthorship W1504439301A5020996390 @default.
• W1504439301 hasAuthorship W1504439301A5026667594 @default.
• W1504439301 hasAuthorship W1504439301A5040417184 @default.
• W1504439301 hasAuthorship W1504439301A5042552205 @default.
• W1504439301 hasAuthorship W1504439301A5058365219 @default.
• W1504439301 hasAuthorship W1504439301A5058925624 @default.
• W1504439301 hasAuthorship W1504439301A5071051754 @default.
• W1504439301 hasAuthorship W1504439301A5081996959 @default.
• W1504439301 hasBestOaLocation W15044393011 @default.
• W1504439301 hasConcept C141071460 @default.
• W1504439301 hasConcept C155806632 @default.
• W1504439301 hasConcept C2776694085 @default.
• W1504439301 hasConcept C2776755627 @default.
• W1504439301 hasConcept C2778880498 @default.
• W1504439301 hasConcept C2911091166 @default.
• W1504439301 hasConcept C2989005 @default.
• W1504439301 hasConcept C509974204 @default.
• W1504439301 hasConcept C71924100 @default.
• W1504439301 hasConcept C75088862 @default.
• W1504439301 hasConceptScore W1504439301C141071460 @default.
• W1504439301 hasConceptScore W1504439301C155806632 @default.
• W1504439301 hasConceptScore W1504439301C2776694085 @default.
• W1504439301 hasConceptScore W1504439301C2776755627 @default.
• W1504439301 hasConceptScore W1504439301C2778880498 @default.
• W1504439301 hasConceptScore W1504439301C2911091166 @default.
• W1504439301 hasConceptScore W1504439301C2989005 @default.
• W1504439301 hasConceptScore W1504439301C509974204 @default.
• W1504439301 hasConceptScore W1504439301C71924100 @default.
• W1504439301 hasConceptScore W1504439301C75088862 @default.
• W1504439301 hasIssue "17" @default.
• W1504439301 hasLocation W15044393011 @default.
• W1504439301 hasLocation W15044393012 @default.
• W1504439301 hasOpenAccess W1504439301 @default.
• W1504439301 hasPrimaryLocation W15044393011 @default.
• W1504439301 hasRelatedWork W1967083059 @default.

• next